Marker Therapeutics, Inc. Skyrocketed
Wed, Jun 21, 2023 at 07:40 PM
Marker Therapeutics, Inc. (MRKR:NASDAQ) jumped higher at $4.2, representing a gain of 21%. On Wed, Jun 21, 2023, MRKR:NASDAQ touched a New 2-Week High of $4.2. The stock appeared on our News Catalysts scanner on Mon, Jun 12, 2023 at 07:27 AM in the 'BIOTECH' category. From Wed, Jun 07, 2023, the stock recorded 77.78% Up Days and 90.00% Green Days
About Marker Therapeutics, Inc. (MRKR:NASDAQ)
TapImmune Inc is developing immunotherapies for a variety of cancers designed to target both tumors and metastatic disease. The company's next-generation technology has been engineered to overcome the deficiencies of earlier cancer vaccine approaches.
Top 10 Gainers:
- Advanced Human Imaging Limited. (AHI:NASDAQ), 101.35%
- Root Inc. (ROOT:NASDAQ), 59.8%
- U Power Limited (UCAR:NASDAQ), 48.49%
- Freightos Limited (CRGO:NASDAQ), 30.3%
- Ocean Biomedical Inc Com (OCEA:NASDAQ), 27.26%
- LumiraDx Limited (LMDX:NASDAQ), 26.57%
- Mullen Automotive Inc. (MULN:NASDAQ), 24.24%
- PureCycle Technologies Inc. (PCT:NASDAQ), 24.06%
- Argo Blockchain plc (ARBK:NASDAQ), 22.41%
- Marker Therapeutics, Inc. (MRKR:NASDAQ), 21.04%